Goodwin + KPMG 7th Annual Symposium @ JP Morgan Healthcare Conference 2026

Transactions to Transformations in Life Sciences of the Future

In today’s market, M&A and strategic transactions are increasingly critical to sustaining innovation and fueling growth for life sciences companies. This year’s symposium will spotlight how industry leaders are leveraging dealmaking—not just as a response to capital constraints, but as a catalyst to advance pipelines, strengthen balance sheets, and position for long-term success.

Through candid discussions and actionable insights, we’ll explore both the art and the mechanics of end-to-end M&A, where the integration of the target is just as important as initial target diligence, the evolving financing landscape, creative partnering strategies, and the role of consolidation in shaping the next era of life sciences.